Asbestos and Mesothelioma

1. Malignant Mesothelioma: An Asbestos Legacy
Joseph R. Testa

2. Asbestos and Fibrous Erionite
Ann G. Wylie

3. Epidemiology of Mesothelioma
Suresh H. Moolgavkar, Ellen T. Chang, Gabor Mezei, Fionna S. Mowat

4. Malignant Pleural Mesothelioma: History, Controversy, and Future of a Man-Made Epidemic
Oluf Dimitri Røe, Giulia Maria Stella

5. Communities at High Risk in the Third Wave of Mesothelioma
Edward A. Emmett, Brigid Cakouros

6. Mesothelioma Pathology
Elizabeth N. Pavlisko, John M. Carney, Thomas A. Sporn, Victor L. Roggli

7. Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases
Joyce K. Thompson, Arti Shukla

8. Germline and Somatic Mutations in Human Mesothelioma and Lessons from Asbestos-Exposed Genetically Engineered Mouse Models
Mitchell Cheung, Craig W. Menges, Joseph R. Testa

9. Gene Signature of Malignant Pleural Mesothelioma
Assunta De Rienzo, William G. Richards, Raphael Bueno

10. Cell Signaling and Epigenetic Mechanisms in Mesothelioma
Brooke T. Mossman

11. 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival
V. Courtney Broaddus, Carlo Follo, Dario Barbone

12. Biomarkers of Response to Asbestos Exposure
Clementina Mesaros, Liwei Weng, Ian A. Blair

13. Surgery Approaches in Mesothelioma
Andrea Wolf, Raja Flores

14. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma
Charles B. Simone, Theresa M. Busch, Keith A. Cengel

15. Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma
Marjorie G. Zauderer

16. Immunotherapeutic Approaches to Mesothelioma
Anish Thomas, Madhuri Badrinath, Raffit Hassan

17. Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections
Kirk Hartley, Mary Hesdorffer

18. The Patient’s Experience of Malignant Mesothelioma
William M. Buchholz

Nyckelord: Biomedicine, Cancer Research